x
Filter:
Filters applied
- Neurobiology
- Chiara, David CRemove Chiara, David C filter
- nicotinic acetylcholine receptors (nAChR)Remove nicotinic acetylcholine receptors (nAChR) filter
Publication Date
Please choose a date range between 2017 and 2019.
Keyword
- ion channel2
- anesthetic1
- CMPI1
- dFBr1
- drug design1
- drug development1
- electrophysiology1
- GABA receptor1
- ligand-gated ion channel1
- lipid-protein interaction1
- neurosteroid allopregnanolone1
- neurotransmitter receptor1
- NS92831
- pentameric ligand-gated ion channel1
- perfluorophenyl azide1
- photolabeling1
- Positive allosteric modulators1
- steroid1
Neurobiology
2 Results
- Protein Structure and FoldingOpen Access
A photoreactive analog of allopregnanolone enables identification of steroid-binding sites in a nicotinic acetylcholine receptor
Journal of Biological ChemistryVol. 294Issue 19p7892–7903Published online: March 28, 2019- Zhiyi Yu
- David C. Chiara
- Pavel Y. Savechenkov
- Karol S. Bruzik
- Jonathan B. Cohen
Cited in Scopus: 2Many neuroactive steroids potently and allosterically modulate pentameric ligand-gated ion channels, including GABAA receptors (GABAAR) and nicotinic acetylcholine receptors (nAChRs). Allopregnanolone and its synthetic analog alphaxalone are GABAAR-positive allosteric modulators (PAMs), whereas alphaxalone and most neuroactive steroids are nAChR inhibitors. In this report, we used 11β-(p-azidotetrafluorobenzoyloxy)allopregnanolone (F4N3Bzoxy-AP), a general anesthetic and photoreactive allopregnanolone analog that is a potent GABAAR PAM, to characterize steroid-binding sites in the Torpedo α2βγδ nAChR in its native membrane environment. - NeurobiologyOpen Access
Unraveling amino acid residues critical for allosteric potentiation of (α4)3(β2)2-type nicotinic acetylcholine receptor responses
Journal of Biological ChemistryVol. 292Issue 24p9988–10001Published online: April 26, 2017- Ze-Jun Wang
- Farah Deba
- Tasnim S. Mohamed
- David C. Chiara
- Kara Ramos
- Ayman K. Hamouda
Cited in Scopus: 12Neuronal nicotinic acetylcholine receptors (nAChRs) are promising drug targets to manage several neurological disorders and nicotine addiction. Growing evidence indicates that positive allosteric modulators of nAChRs improve pharmacological specificity by binding to unique sites present only in a subpopulation of nAChRs. Furthermore, nAChR positive allosteric modulators such as NS9283 and CMPI have been shown to potentiate responses of (α4)3(β2)2 but not (α4)2(β2)3 nAChR isoforms. This selective potentiation underlines that the α4:α4 interface, which is present only in the (α4)3(β2)2 nAChR, is an important and promising drug target.